Skip to main content

Advertisement

SpringerLink
  • Log in
  1. Home
  2. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  3. Article
Mycobacterium tuberculosis
Download PDF
Download PDF
  • Bekanntmachungen – Amtliche Mitteilungen
  • Published: 27 December 2017

Mycobacterium tuberculosis

Stellungnahmen des Arbeitskreises Blut des Bundesministeriums für Gesundheit

    Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz volume 61, pages 100–115 (2018)Cite this article

    • 1480 Accesses

    • 1 Altmetric

    • Metrics details

    Download to read the full article text

    Working on a manuscript?

    Avoid the common mistakes

    Literatur

    1. World Health Organisation (2016) Global tuberculosis report 2016. http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1. Zugegriffen: 25. Juli 2017

      Google Scholar 

    2. Fiebig L, Hauer B, Brodhun B, Altmann D, Haas W (2016) Tuberculosis in Germany: a declining trend coming to an end? Eur Respir J 47(2):667–670

      Article  PubMed  Google Scholar 

    3. Hauer B, Fiebig L, Brodhun B, Rexroth U, Haas W (2014) Aktuelle Epidemiologie der Tuberkulose weltweit, in Europa und in Deutschland. Pneumologe 11(1):10–20

      Article  Google Scholar 

    4. Loddenkemper R, Hauer B (2010) Resistente Tuberkulose: Große Herausforderung durch eine Weltepidemie. Dtsch Arztebl Int 107(1):10–19

      PubMed  PubMed Central  Google Scholar 

    5. World Health Organization (2017) Global strategy and targets for tuberculosis prevention, care and control after 2015. Fact sheet 2014. http://www.who.int/tb/post2015_TBstrategy.pdf?ua=1. Zugegriffen: 25. Juli 2017

      Google Scholar 

    6. Lönnroth K, Migliori GB, Abubakar I et al (2015) Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 45(4):928–952

      PubMed  PubMed Central  Google Scholar 

    7. European Centre for Disease prevention and Control (ECDC) / WHO Regional Office for Europe (2017) Tuberculosis surveillance and monitoring in Europe, 2017. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/ecdc-tuberculosis-surveillance-monitoring-Europe-2017.pdf. Zugegriffen: 25. Juli 2017

      Google Scholar 

    8. Houben RMGJ, Dodd PJ (2016) The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med 13(10):1–13

      Article  Google Scholar 

    9. Koch R (1882) Die Aetiologie der Tuberculose. Berl Medizinische Wochenschrift 19:221–230

      Google Scholar 

    10. Cole ST, Brosch R, Parkhill J et al (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393(6685):537–544

      Article  CAS  PubMed  Google Scholar 

    11. Gheorghiu M (1996) Antituberculosis BCG vaccine: lessons from the past. In: Plotkin SA, Fantini B (Hrsg) Vaccinia, Vaccination, Vaccinology. Elsevier, Paris, S 87–96

      Google Scholar 

    12. Hesseling AC, Johnson LF, Jaspan H et al (2009) Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants. Bull World Health Org 87(7):505–511

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    13. Lamm DL, van der Meijden PM, Morales A et al (1992) Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 147(3):596–600

      Article  CAS  PubMed  Google Scholar 

    14. Xie J, Codd C, Mo K, He Y (2016) Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis. PLOS ONE 11(10):e164792. https://doi.org/10.1371/journal.pone.0164792

      Article  PubMed  PubMed Central  CAS  Google Scholar 

    15. Gantzer A, Neven B, Picard C et al (2013) Severe cutaneous bacillus Calmette-Guérin infection in immunocompromised children: the relevance of skin biopsy. J Cutan Pathol 40(1):30–37

      Article  PubMed  Google Scholar 

    16. Britton WJ, Lockwood DN (2004) Leprosy. Lancet 363(9416):1209–1219

      Article  PubMed  Google Scholar 

    17. Stellungnahme des Arbeitskreis Blut (2016) Mycobacterium leprae – Der Erreger von Lepra. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 59:1508–1521

      Article  Google Scholar 

    18. Schönfeld N, Haas W, Richter E et al (2013) Empfehlungen zur Diagnostik und Therapie nichttuberkulöser Mykobakteriosen des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP). Pneumologie 67:605–633

      Article  PubMed  Google Scholar 

    19. Minnikin DE, Lee OYC, Wu HHT et al (2015) Ancient mycobacterial lipids: Key reference biomarkers in charting the evolution of tuberculosis. Tuberculosis, Bd. 95., S 133–S139

      Google Scholar 

    20. Arbues A, Lugo-Villarino GC, Neyrolles O, Guilhot C, Astarie-Dequeker C (2014) Playing hide-and-seek with host macrophages through the use of mycobacterial cell envelope phthiocerol dimycocerosates and phenolic glycolipids. Front Cell Inf 4(173):1–7

      Google Scholar 

    21. Ulrichs T, Kaufmann SHE (2003) Immunologie der Tuberkulose. Internist 44(11):1374–1384

      Article  CAS  PubMed  Google Scholar 

    22. Ulrichs T (2009) Immunologie der Tuberkulose und Impfstoffentwicklung. In: Forßbohm M, Loytved G, Königstein B (Hrsg) Handbuch Tuberkulose für Fachkräfte an Gesundheitsämtern, 1. Aufl. Akademie für öffentliches Gesundheitswesen, Düsseldorf

      Google Scholar 

    23. Hauer B, Rohde D, Loddenkemper R (2005) Tuberkulose. Der. Pneumologe 2:291–306

      Article  Google Scholar 

    24. Kaufmann SHE (1999) Die Immunantwort gegen Tuberkulose. In: Konietzko N, Loddenkemper R (Hrsg) Tuberkulose. Thieme, Stuttgart, S 62–78

      Google Scholar 

    25. Kaufmann SH (2013) Tuberculosis vaccines: time to think about the next generation. Semin Immunol 25(2):172–181

      Article  CAS  PubMed  Google Scholar 

    26. Pai M, Behr MA, Dowdy D et al (2016) Tuberculosis Disease Primer. Nat Rev 2:1–23

      Google Scholar 

    27. Manabe YC, Bishai WR (2000) Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat Med 6(12):1327–1329

      Article  CAS  PubMed  Google Scholar 

    28. Corbett EL, Watt CJ, Walker N et al (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163(9):1009–1021

      Article  PubMed  Google Scholar 

    29. Lienhardt C, Rodrigues LC (1997) Estimation of the impact of the human immunodeficiency virus infection on tuberculosis: tuberculosis risks re-visited? Int J Tuberc Lung Dis 1(3):196–204

      CAS  PubMed  Google Scholar 

    30. Ehlers S (2005) Why does tumor necrosis factor targeted therapy reactivate tuberculosis? J Rheumtol Suppl 74:35–39

      CAS  Google Scholar 

    31. Diel R, Hauer B, Loddenkemper R, Manger B, Krüger K (2009) Empfehlungen für das Tuberkulosescreening vor Gabe von TNF-α-Inhibitoren bei rheumatischen Erkrankungen. Pneumologie 63:329–334

      Article  CAS  PubMed  Google Scholar 

    32. Marx FM, Dunbar R, Enarson DA et al (2014) The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study. Clin Infect Dis 58(12):1676–1683

      Article  CAS  PubMed  Google Scholar 

    33. Lee ES, Yoon TH, Lee MY, Han SH, Ka JO (2010) Inactivation of environmental mycobacteria by free chlorine and UV. Water Res 44:13299–11334

      Google Scholar 

    34. Murdoch LE, Maclean M, Endarko E, MacGregor SJ, Anderson JG (2012) Bactericidal effects of 405 nm light exposure demonstrated by inactivation of Escherichia, Salmonella, Shigella, Listeria, and Mycobacterium species in liquid suspension and on exposed surfaces. Sci World J. https://doi.org/10.1100/2012/137805

      Google Scholar 

    35. Fine AE, Bolin CA, Gardiner JC, Kaneene JB (2012) A study of the persistence of Mycobacterium bovis in the environment under natural weather conditions in Michigan, USA. Vet Med Int 26:765430

      Google Scholar 

    36. Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on inanimate surfaces. A systematic review. Bmc Infect Dis 6:130

      Article  PubMed  PubMed Central  Google Scholar 

    37. Ziegler R, Just HM, Castell S et al (2012) Infektionsprävention bei Tuberkulose – Empfehlungen des DZK. Gesundheitswesen 74(6):337–350

      Article  CAS  PubMed  Google Scholar 

    38. Robert Koch-Institut (2013) Liste der vom Robert Koch-Institut geprüften und anerkannten Desinfektionsmittel und –verfahren. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 56:1706–1728

      Article  Google Scholar 

    39. Wells WF (1955) Airborne contagion and air hygiene. An ecological study of droplet infection. Harvard University Press, Cambridge (MA)

      Google Scholar 

    40. Rieder HL (1999) Epidemiologic Basis of Tuberculosis Control. International Union Against Tuberculosis and Lung Disease, Paris

      Google Scholar 

    41. Diel R, Loytved G, Nienhaus A et al (2011) Neue Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose. Gesundheitswesen 73(6):369–388

      Article  CAS  PubMed  Google Scholar 

    42. Keijmann J, Tjhie J, Damink OS, Alink M (2001) Unusual nosocomial transmission of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 20:808–809

      Article  Google Scholar 

    43. Hutton MD, Stead WW, Cauthen GM, Bloch AB, Ewing WM (1990) Nosocomial transmission of tuberculosis associated with a draining abscess. J Infect Dis 161:286–295

      Article  CAS  PubMed  Google Scholar 

    44. Comstock GW, Livesay VT, Woolpert SF (1974) The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 99(2):131–138

      Article  CAS  PubMed  Google Scholar 

    45. Vynnycky E, Fine PE (2000) Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol 152(3):247–263

      Article  CAS  PubMed  Google Scholar 

    46. Mack U, Migliori GB, Sester M et al (2009) LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33(5):956–973

      Article  CAS  PubMed  Google Scholar 

    47. Horsburgh CR (2004) Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 350:2060–2067

      Article  CAS  PubMed  Google Scholar 

    48. Marais BJ, Gie RP, Schaaf HS et al (2004) The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 8(4):392–402

      CAS  PubMed  Google Scholar 

    49. Cruz AT, Starke JR (2010) Pediatric tuberculosis. Pediatr Rev 31(1):13–25

      Article  PubMed  Google Scholar 

    50. Shaw JB, Wynn-Williams N (1954) Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 69(5):724–732

      CAS  PubMed  Google Scholar 

    51. Riley RL (1983) The contagiosity of tuberculosis. Schweiz Med Wochenschr 113:75–79

      CAS  PubMed  Google Scholar 

    52. Sepkowitz KA (1996) How contagious is tuberculosis? Clin Infect Dis 23:954–962

      Article  CAS  PubMed  Google Scholar 

    53. Behr MA, Warren SA, al Salamon Het (1999) Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353(9151):444–449

      Article  CAS  PubMed  Google Scholar 

    54. Tostmann A, Kik SV, Kalisvaart NA et al (2008) Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis 47(9):1135–1142

      Article  PubMed  Google Scholar 

    55. Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B (2008) Paediatric tuberculosis. Lancet Inf Dis 8(8):498–510

      Article  Google Scholar 

    56. Loudon RG, Spohn SK (1969) Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Respir Dis 99(1):109–111

      CAS  PubMed  Google Scholar 

    57. Fennelly KP, Martyny JW, Fulton KE, Orme IM, Cave DM, Heifets LB (2004) Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness. Am J Respir Crit Care Med 169(5):604–609

      Article  PubMed  Google Scholar 

    58. Loudon RG, Roberts RM (1966) Droplet expulsion from the respiratory tract. Am Rev Respir Dis 95:435–442

      Google Scholar 

    59. Dharmadhikari AS, Mphahlele M, Venter K et al (2014) Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 18(9):1019–1025

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    60. Rouillon A, Perdrizet S, Parrot R (1976) Transmission of tubercle bacilli: The effects of chemotherapy. Tubercle 57(4):275–299

      Article  CAS  PubMed  Google Scholar 

    61. Chapman JS, Dyerly MD (1964) Social and other factors in intrafamilial transmission of tuberculosis. Am Rev Respir Dis 90:48–60

      CAS  PubMed  Google Scholar 

    62. Loudon RG, Williamson J, Johnson JM (1958) An analysis of 3,485 tuberculosis contacts in the city of Edinburgh during 1954-1955. Am Rev Tuberc 77(4):623–643

      CAS  PubMed  Google Scholar 

    63. Riley RL, Mills CC, O'Grady F, Sultan LU, Wittstadt F, Shivpuri DN (1962) Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients. Am Rev Respir Dis 85:511–525

      CAS  PubMed  Google Scholar 

    64. Golub JE, Cronin WA, Obasanjo OO et al (2001) Transmission of Mycobacterium tuberculosis through casual contact with an infectious case. Arch Intern Med 161(18):2254–2258

      Article  CAS  PubMed  Google Scholar 

    65. Smith S, Jacobs RF, Wilson CB (1997) Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J Pediatr 131:16–26

      Article  CAS  PubMed  Google Scholar 

    66. Guzzetta G, Kirschner D (2013) The roles of immune memory and aging in protective immunity and endogenous reactivation of tuberculosis. PLOS ONE 8(4):e60425

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    67. Nhamoyebonde S, Leslie A (2014) Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis 15(Suppl 3):100–106

      Article  Google Scholar 

    68. Selwyn PA, Hartel D, Lewis VA et al (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320:545–550

      Article  CAS  PubMed  Google Scholar 

    69. Bucher HC, Griffith LE, Guyatt GH et al (1999) Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS 13:501–507

      Article  CAS  PubMed  Google Scholar 

    70. Girardi E, Antonucci G, Vanacore P et al (2000) Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 14:1985–1991

      Article  CAS  PubMed  Google Scholar 

    71. Schaberg T, Bauer T, Castell S et al (2012) Empfehlungen zur Therapie, Chemoprävention und Chemoprophylaxe der Tuberkulose im Erwachsenen- und Kindesalter. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose, Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie 66(3):133–171

      Article  CAS  PubMed  Google Scholar 

    72. Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5(7):e152

      Article  PubMed  PubMed Central  Google Scholar 

    73. Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N (2014) Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology 144(2):171–185

      Article  CAS  Google Scholar 

    74. Slama K, Chiang CY, Enarson DA et al (2007) Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 11(10):1049–1061

      CAS  PubMed  Google Scholar 

    75. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR (2007) Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 167(4):335–342

      Article  PubMed  Google Scholar 

    76. Story A, Murad S, Roberts W et al (2007) Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax 62(8):667–671

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    77. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M (2009) Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 68(12):2240–2246

      Article  PubMed  Google Scholar 

    78. Lacerda SNB, de Abreu Temoteo RC, Monteiro de Figueiredo TMR et al (2014) Individual and social vulnerabilities upon acquiring tuberculosis: a literature systematic review. Int Arch Med 12(7):35

      Article  Google Scholar 

    79. van Hest NA, Aldridge RW, de Vries G et al (2014) Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement. Euro Surveill 19(2072):9

      Google Scholar 

    80. Robert Koch-Institut (2013) Tuberkulose. RKI-Ratgeber für Ärzte. http://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Tuberkulose.html. Zugegriffen: 25. Juli 2017

      Google Scholar 

    81. Haas W, Brodhun B, Starker A (2006) Tuberkulose. Gesundheitsberichterstattung des Bundes, Heft 35. Robert Koch-Institut, Berlin

      Google Scholar 

    82. Magdorf K, Bialek R, Detjen AK et al (2013) Tuberkulose und nichttuberkulöse mykobakterielle Krankheiten. In: DGPI Handbuch. Infektionen bei Kindern und Jugendlichen, 6. Aufl. Deutsche Gesellschaft für Pädiatrische Infektiologie e.V. Georg Thieme Verlag KG, Stuttgart, S 551–570

    83. Siemon G, Kropp R (1999) Diagnose und Differentialdiagnose der pulmonalen und extrapulmonalen Tuberkulose. In: Konietzko N, Loddenkemper R (Hrsg) Tuberkulose. Thieme, Stuttgart

      Google Scholar 

    84. Liebermeister G (1909) Studien über Komplikationen der Lungentuberkulose und über die Verbreitung der Tuberkelbazillen in Organen und im Blut der Phtisiker. Virchows Arch F Path Anat 197:332

      Article  Google Scholar 

    85. Faber HK (1914) A culture of bacillus tuberculosis from the blood post mortem of a case of miliary tuberculosis. JAMA 63:1656–1658

      Article  Google Scholar 

    86. Clough MC (1917) The cultivation of tubercle bacilli from the circulation blood in miliary tuberculosis. Am Rev Tuberc 1:598–621

      Google Scholar 

    87. Ho RS, Fok JS, Harding GE, Smith DW (1978) Host-parasite relationships in experimental airborne tuberculosis. VII. Fate of Mycobacterium tuberculosis in primary lung lesions and in primary lesion-free lung tissue infected as a result of bacillemia. J Infect Dis 138(2):237–241

      Article  CAS  PubMed  Google Scholar 

    88. McMurray DN (2003) Hematogenous reseeding of the lung in low-dose, aerosol-infected guinea pigs: unique features of the host-pathogen interface in secondary tubercles. Tuberculosis 83(1):131–134

      Article  PubMed  Google Scholar 

    89. Saltzman BR, Motyl MR, Friedland GH, McKitrick JC, Klein RS (1986) Mycobacterium tuberculosis bacteremia in the acquired immunodeficiency syndrome. JAMA 256:390–391

      Article  CAS  PubMed  Google Scholar 

    90. Barber TW, Craven DE, McCabe WR (1990) Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literature. Medicine (Baltimore) 69(6):375–383

      Article  CAS  Google Scholar 

    91. Bouza E, Díaz-López MD, Moreno S, Bernaldo de Quirós JC, Vicente T, Berenguer J (1993) Mycobacterium tuberculosis bacteremia in patients with and without human immunodeficiency virus infection. Arch Intern Med 153(4):496–500

      Article  CAS  PubMed  Google Scholar 

    92. Sharafeldin GS, Khalil EA, El Hag IA et al (2007) Haematogenous dissemination of tuberculous lymphadenitis. East Afr Med J 84(1):3–7

      Article  CAS  PubMed  Google Scholar 

    93. Schluger NW, Condos R, Lewis S, Rom WN (1994) Amplification of DNA of Mycobacterium tuberculosis from peripheral blood of patients with pulmonary tuberculosis. Lancet 344(8917):232–233

      Article  CAS  PubMed  Google Scholar 

    94. Shafer RW, Goldberg R, Sierra M, Glatt AE (1989) Frequency of Mycobacterium tuberculosis bacteremia in patients with tuberculosis in an area endemic for AIDS. Am Rev Respir Dis 140(6):1611–1613

      Article  CAS  PubMed  Google Scholar 

    95. Esteban J, de Gorgolas M, Santos-O'Connor F, Gadea I, Fernández-Roblas R, Soriano F (2001) Mycobacterium tuberculosis bacteremia in a university hospital. Int J Tuberc Lung Dis 5(8):763–768

      CAS  PubMed  Google Scholar 

    96. Chiu YS, Wang JT, Chang SC et al (2007) Mycobacterium tuberculosis bacteremia in HIV-negative patients. J Formos Med Assoc 106(5):355–364

      Article  PubMed  Google Scholar 

    97. Gopinath K, Kumar S, Singh S (2008) Prevalence of mycobacteremia in Indian HIV-infected patients detected by the MB/BacT automated culture system. Eur J Clin Microbiol Infect Dis 27(6):423–431

      Article  CAS  PubMed  Google Scholar 

    98. El Sahly HM, Teeter LD, Musser JM, Graviss EA (2014) Mycobacterium tuberculosis bacteraemia: experience from a non-endemic urban centre. Clin Microbiol Infect 20(3):263–268

      Article  PubMed  Google Scholar 

    99. Lewis DK, Peters RP, Schijffelen MJ et al (2002) Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre. Malawi Int J Tuberc Lung Dis 6(12):1067–1074

      CAS  PubMed  Google Scholar 

    100. Jacob ST, Pavlinac PB, Nakiyingi L et al (2013) Mycobacterium tuberculosis bacteremia in a cohort of HIV-infected patients hospitalized with severe sepsis in Uganda–high frequency, low clinical suspicion [corrected] and derivation of a clinical prediction score. PLOS ONE 8(8):e70305

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    101. Crump JA, Ramadhani HO, Morrissey AB et al (2012) Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study. Clin Infect Dis 55(2):242–250

      Article  PubMed  PubMed Central  Google Scholar 

    102. Ryndak MB, Singh KK, Peng Z et al (2014) Transcriptional profiling of Mycobacterium tuberculosis replicating ex vivo in blood from HIV- and HIV+ subjects. PLOS ONE 9(4):e94939–22

      Article  PubMed  PubMed Central  CAS  Google Scholar 

    103. Pavlinac PB, Lokken EM, Walson JL, Richardson BA, Crump JA, John-Stewart GC (2016) Mycobacterium tuberculosis bacteremia in adults and children: a systematic review and meta-analysis. Int J Tuberc Lung Dis 20(7):895–902

      Article  CAS  PubMed  Google Scholar 

    104. Nationales Referenzzentrum für Mykobakterien (2014) Präanalytikhandbuch. http://www.fz-borstel.de/cms/fileadmin/content_fz/downloads/Referenzzentrum/NRZ-Praeanalytik.pdf. Zugegriffen: 25. Juli 2017

      Google Scholar 

    105. Kropp R, Siemon G (1999) Therapie der Tuberkulose. In: Konietzko N, Loddenkemper R (Hrsg) Tuberkulose. Thieme, Stuttgart, S 137

      Google Scholar 

    106. Moon MS, Kim SS, Moon YW, Moon H, Kim SS (2014) Surgery-related complications and sequelae in management of tuberculosis of spine. Asian Spine J 8(4):435–445

      Article  PubMed  PubMed Central  Google Scholar 

    107. Chiang SS, Khan FA, Milstein MB et al (2014) Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 14(10):947–957

      Article  PubMed  Google Scholar 

    108. Van der Walt M, Lancaster J, Odendaal R, Davis JG, Shean K, Farley J (2013) Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients. PLOS ONE 8(4):e58817

      Article  PubMed  PubMed Central  CAS  Google Scholar 

    109. Sturdy A, Goodman A, José RJ et al (2011) Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice. J Antimicrob Chemother 66(8):1815–1820

      Article  CAS  PubMed  Google Scholar 

    110. Avong YK, Isaakidis P, Hinderaker SG et al (2015) Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria. PLOS ONE 10(3):e120161

      Article  PubMed  PubMed Central  CAS  Google Scholar 

    111. Wilderotter H (1995) Das große Sterben - Seuchen machen Geschichte. Jovis Verlag, Berlin

      Google Scholar 

    112. Infektionsschutzgesetz (2000) Bundesgesetzblatt Teil I G5702, S. 1045, Bonn

    113. Forßbohm M, Loytved G, Hauer B (2009) Auswirkungen des Infektionsschutzgesetzes auf die Erfassung der Tuberkulose. In: Forßbohm M, Loytved G, Königstein B (Hrsg) Handbuch Tuberkulose für Fachkräfte an Gesundheitsämtern, 1. Aufl. Akademie für öffentliches Gesundheitswesen, Düsseldorf

      Google Scholar 

    114. Robert Koch-Institut (2016) Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2016. Robert Koch-Institut, Berlin

      Google Scholar 

    115. Dedié K, Bockemühl J, Kühn H, Volkmer K-J, Weinke T (1993) Bakterielle Zoonosen bei Tier und Mensch. Enke Verlag, Stuttgart

      Google Scholar 

    116. Humblet M-F, Boschiroli ML, Saegerman C (2009) Classification of worldwide bovine tuberculosis risk factors in cattle: a stratified approach. Vet Res 40:50

      Article  PubMed  PubMed Central  Google Scholar 

    117. Snider D (1984) Pregnancy and tuberculosis. Chest 86:10S–13S

      Article  CAS  PubMed  Google Scholar 

    118. Whittaker E, Kampmann B (2008) Perinatal tuberculosis. New challenges in the diagnosis and treatment of tuberculosis in infants and the newborn. Early Hum Dev 84:795–799

      Article  PubMed  Google Scholar 

    119. Mittal H, Das S, Faridi MM (2014) Management of newborn infant born to mother suffering from tuberculosis: Current recommendations & gaps in knowledge. Indian J Med Res 140(1):32–39

      PubMed  PubMed Central  Google Scholar 

    120. Gartner LM, Morton J, Lawrence RA et al (2005) Breastfeeding and the use of human milk. Pediatrics 115(2):496–506

      Article  PubMed  Google Scholar 

    121. Subramanian AK (2014) Tuberculosis in solid organ transplant candidates and recipients: current and future challenges. Curr Opin Infect Dis 27(4):316–321

      Article  PubMed  Google Scholar 

    122. Bumbacea D, Arend SM, Eyuboglu F et al (2012) The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J 40(4):990–1013

      Article  PubMed  Google Scholar 

    123. Morris MI, Daly JS, Blumberg E et al (2012) Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report. Am J Transplant 12(9):2288–2300

      Article  CAS  PubMed  Google Scholar 

    124. Adamu B, Abdu A, Abba AA, Borodo MM, Tleyjeh IM (2014) Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis (Review). Cochrane Database Syst Rev 4(3):CD8597

      Google Scholar 

    125. Ridgeway AL, Warner GS, Phillips P et al (1996) Transmission of Mycobacterium tuberculosis to recipients of single lung transplants from the same donor. Am J Respir Critical Care Med 153(3):1166–1168

      Article  CAS  Google Scholar 

    126. Winthrop KL, Kubak BM, Pegues DA et al (2004) Transmission of mycobacterium tuberculosis via lung transplantation. Am J Transplant 4(9):1529–1533

      Article  PubMed  Google Scholar 

    127. Kiuchi T, Inomata Y, Uemoto S et al (1997) A hepatic graft tuberculosis transmitted from a living-related donor. Transplantation 63(6):905–907

      Article  CAS  PubMed  Google Scholar 

    128. Graham JC, Kearns AM, Magee JG et al (2001) Tuberculosis transmitted through transplantation. J Infect 43(4):251–254

      Article  CAS  PubMed  Google Scholar 

    129. Weile J, Eickmeyer H, Dreier J et al (2013) First case of Mycobacterium tuberculosis transmission by heart transplantation from donor to recipient. Int J Med Microbiol 303(8):449–451

      Article  PubMed  Google Scholar 

    130. Kramer F, Sasse SA, Simms JC, Leedom JM (1993) Primary cutaneous tuberculosis after a needle stick injury from a patient with AIDS and undiagnosed tuberculosis. Ann Intern Med 119:594–595

      Article  CAS  PubMed  Google Scholar 

    131. Belchior I, Seabra B, Duarte R (2011) Primary inoculation skin tuberculosis by accidental needle stick. BMJ Case Rep. https://doi.org/10.1136/bcr.11.2010.3496

      PubMed  PubMed Central  Google Scholar 

    132. Liu Y, Pan J, Jin K et al (2014) Analysis of 30 patients with acupuncture-induced primary inoculation tuberculosis. PLOS ONE 9(6):e100377

      Article  PubMed  PubMed Central  CAS  Google Scholar 

    133. Wang J, Zhu MY, Li C et al (2014) Outbreak of primary inoculation tuberculosis in an acupuncture clinic in southeastern China. Epidemiol Infect 22:1–6

      CAS  Google Scholar 

    134. O´Leary PA, Harrison MW (1941) Inoculation tuberculosis. Arch Dermatology Syph 44:371–390

      Article  Google Scholar 

    135. Goette DK, Jacobson KW, Doty RD (1978) Primary inoculation tuberculosis of the skin. Protector´s paronychia. Arch Dermatol 114:567–569

      Article  CAS  PubMed  Google Scholar 

    136. Diel R, Bauer T, Schaberg T (2013) Tuberkulose Fortschritte in den letzten 10 Jahren und Perspektiven für die weitere Entwicklung. Pneumologe 10:39–46

      Article  Google Scholar 

    137. World Health Organization (2011) Collaborative framework for care and control of tuberculosis and diabetes. http://whqlibdoc.who.int/publications/2011/9789241502252_eng.pdf. Zugegriffen: 25. Juli 2017

      Google Scholar 

    138. Mo P, Zhu Q, Teter C et al (2014) Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus. Int J Infect Dis 9(28):95–100

      Article  Google Scholar 

    139. Merker M, Mona S, Duforet-Frebourg N et al (2015) Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nat Genet 47(3):242–249

      Article  CAS  PubMed  Google Scholar 

    140. Fiebig L, Kollan C, Hauer B et al (2012) HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data. PLOS ONE 7(11):e49111

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    141. Moser I, Köhler H, Menge C (2014) Die Tuberkulose des Rindes – überraschend wieder oder immer noch präsent? Tierarztl Prax Ausg G Grosstiere Nutztiere 42(4):240–249

      CAS  PubMed  Google Scholar 

    142. Prodinger WM, Eigentler A, Allerberger F et al (2002) Infection of red deer, cattle, and humans with Mycobacterium bovis subsp. caprae in Western Austria. J Clin Microbiol 40:2270–2272

      Article  PubMed  PubMed Central  Google Scholar 

    143. Kaneene JB, Miller R, de Kantor IN, Thoen CO (2010) Tuberculosis in wild animals. Int J Tuberc Lung Dis 14:1508–1512

      CAS  PubMed  Google Scholar 

    144. Une Y, Mori T (2007) Tuberculosis as a zoonosis from a veterinary perspective. Comp Immun Microbiol Infect Dis 30:415–425

      Article  Google Scholar 

    145. Washko RM, Hoefer H, Kiehn TE et al (1998) Mycobacterium tuberculosis infection in a green-winges macaw (Ara chloroptera): report with Public Health implications. J Clin Mirobiol 36:1101–1102

      CAS  Google Scholar 

    146. Roberts T, O'Connor C, Nuñez-Garcia J, de la Rua-Domenech R, Smith NH (2014) Unusual cluster of Mycobacterium bovis infection in cats. Vet Rec 174(13):326

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    147. Khattak I, Mushtaq MH, Ahmad MU, Khan MS, Haider J (2016) Zoonotic tuberculosis in occupationally exposed groups in Pakistan. Occup Med 66(5):371–376

      Article  CAS  Google Scholar 

    148. Gutierrez M, Samper S, Jimenez MS, van Embden JD, Marin JF, Martin C (1997) Identification by spoligotyping of a caprine genotype in Mycobacterium bovis strains causing human tuberculosis. J Clin Microbiol 35:3328–3330

      CAS  PubMed  PubMed Central  Google Scholar 

    149. Schmidt V, Schneider S, Schlömer J et al (2008) Transmission of tuberculosis between men and pet birds: a case report. Avian Pathol 37:589–592

      Article  PubMed  Google Scholar 

    150. Panteix G, Gutierrez MC, Boschiroli ML et al (2010) Pulmonary tuberculosis due to Mycobacterium microti: a study of six recent cases in France. J Med Microbiol 59:984–989

      Article  CAS  PubMed  Google Scholar 

    151. Cousins DV, Bastida R, Cataldi A et al (2003) Tuberculosis in seals caused by a novel member of the Mycobacterium tuberculosis complex: Mycobacterium pinnipedii sp. Nov Int J Syst Evol Microbiol 53:1305–1314

      Article  CAS  PubMed  Google Scholar 

    152. Falldefinitionen des Robert Koch-Instituts zur Übermittlung von Erkrankungs- oder Todesfällen und Nachweisen von Krankheitserregern. Ausgabe 2015 gemäß § 4 Abs. 2 des Gesetzes zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz – IfSG) http://www.rki.de/DE/Content/Infekt/IfSG/Falldefinition/Downloads/Falldefinitionen_des_RKI.pdf?__blob=publicationFile. Zugegriffen 25. Juli 2017

    153. Robert Koch-Institut (2004) Leitfaden zur Übermittlung von Fallberichten zur Tuberkulose. https://www.rki.de/DE/Content/InfAZ/T/Tuberkulose/Download/TB_Leitfaden.pdf?__blob=publicationFile. Zugegriffen: 25. Juli 2017

      Google Scholar 

    154. Richter E, Beer J, Diel R et al (2010) MIQ 5: Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. In: Podbielski A, Herrmann M, Kniehl E, Mauch H, Rüssmann H (Hrsg) Heft Tuberkulose / Mykobakteriose, 2010. Aufl. Bd. 2.

      Google Scholar 

    155. Boyle D, Pai M (2015) UNITAID Tuberculosis Diagnostics Technology & Market Landscape, 4. Aufl. UNITAID, Vernierhttps://unitaid.eu/assets/Tuberculosis_diagnostics_technology_and_market_landscape_4th_edition_Oct_2015-1.pdf. Zugegriffen: 8. November 2017

    156. Hillemann D, Rüsch- Gerdes S, Richter E (2011) Neue molekulardiagnostische Verfahren in der Tuberkulose-Diagnostik. Epi Bull 34:319–321

      Google Scholar 

    157. Ling DI, Flores LL, Riley LW, Pai M (2008) Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLOS ONE 3(2):e1536

      Article  PubMed  PubMed Central  CAS  Google Scholar 

    158. Mc Hugh TD (2013) Tuberculosis: Diagnosis and Treatment in Advances in molecular and cellular microbiology. CABI, Boston‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬

      Google Scholar 

    159. Kohl TA, Niemann S (2015) Gesamtgenomsequenzierung als Mittel zur Aufklärung von Übertragungswegen und Resistenzen von Mycobacterium tuberculosis-Komplex-Stämmen. Epi Bull 11(12):90–91

      Google Scholar 

    160. Walker TM, Kohl TA, Omar SV et al (2015) Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Inf Dis 15:1193–1202

      Article  CAS  Google Scholar 

    161. Hirtl T (2000) Das Tuberkulin. Von der Geschichte der Tuberkulin-Anwendung über eine Bestandsaufnahme der Gegenwart bis zum Ausblick in eine geforderte Zukunft. Schriftenreihe Gesund in Wien. Literas Universitätsverlag Ges.m.b.H., Wien

      Google Scholar 

    162. Sagebiel D, Magdorf K, Loddenkemper R (2005) Von der WHO empfohlenes Tuberkulin PPD RT 23 SSI in Deutschland zugelassen. Pneumologie 59(11):761–762

      Article  CAS  PubMed  Google Scholar 

    163. Hauer B, Loddenkemper R, Detjen A et al (2006) Interferon-γ-Tests in der Tuberkulose-Diagnostik - Aktueller Stand. Pneumologie 60:29–44

      Article  CAS  PubMed  Google Scholar 

    164. World Health Organization (2011) Commercial serodiagnostic tests for diagnosis of tuberculosis. Policy Statement: 2011. http://apps.who.int/iris/bitstream/10665/70684/1/WHO_HTM_TB_2011.14_eng.pdf?ua=1. Zugegriffen: 25. Juli 2017

      Google Scholar 

    165. Hauer B, Diel R, Priwitzer M, Rüsch-Gerdes S, Schaberg T, Loddenkemper R (2008) Der neue Tuberkulose-Schnelltest von Diavita – keine Verbesserung der diagnostischen Möglichkeiten. Pneumologie 62(8):480–481

      Article  CAS  PubMed  Google Scholar 

    166. WHO (2016) Treatment guidelines for drug-resistant tuberculosis – 2016 update. http://www.who.int/tb/areas-of-work/drug-resistant-tb/MDRTBguidelines2016.pdf. Zugegriffen: 25. Juli 2017

      Google Scholar 

    167. Lange C, Abubakar I, Alffenaar JW et al (2014) Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J 44(1):23–63

      Article  PubMed  PubMed Central  Google Scholar 

    168. Arbeitskreis Tuberkulose im Fachausschuss Infektionsschutz des Berufsverbandes der Ärztinnen und Arzte des ÖGD (2012) Sicherung des Behandlungserfolges bei Tuberkulose. Epid Bull 11:93–95

      Google Scholar 

    169. Kempker RR, Vashakidze S, Solomonia N, Dzidzikashvili N, Blumberg HM (2012) Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis 12(2):157-166

    170. St IK (1998) Mitteilung der Ständigen Impfkommission am Robert Koch-Institut: Impfempfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epid Bull 15:98

      Google Scholar 

    171. World Health Organization (2004) BCG vaccine. WHO position paper. Wkly Epidemiol Rec 79(4):27–38

      Google Scholar 

    172. Bundesärztekammer (2010) Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). http://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/RiliHaemotherapie2010.pdf. Zugegriffen: 25. Juli 2017

      Google Scholar 

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Mycobacterium tuberculosis. Bundesgesundheitsbl 61, 100–115 (2018). https://doi.org/10.1007/s00103-017-2660-4

    Download citation

    • Published: 27 December 2017

    • Issue Date: January 2018

    • DOI: https://doi.org/10.1007/s00103-017-2660-4

    Share this article

    Anyone you share the following link with will be able to read this content:

    Sorry, a shareable link is not currently available for this article.

    Provided by the Springer Nature SharedIt content-sharing initiative

    Download PDF

    Working on a manuscript?

    Avoid the common mistakes

    Advertisement

    Over 10 million scientific documents at your fingertips

    Switch Edition
    • Academic Edition
    • Corporate Edition
    • Home
    • Impressum
    • Legal information
    • Privacy statement
    • California Privacy Statement
    • How we use cookies
    • Manage cookies/Do not sell my data
    • Accessibility
    • FAQ
    • Contact us
    • Affiliate program

    Not logged in - 3.239.6.58

    Not affiliated

    Springer Nature

    © 2023 Springer Nature Switzerland AG. Part of Springer Nature.